TW202132269A - 登革熱疾病及治療和預防 - Google Patents
登革熱疾病及治療和預防 Download PDFInfo
- Publication number
- TW202132269A TW202132269A TW109139793A TW109139793A TW202132269A TW 202132269 A TW202132269 A TW 202132269A TW 109139793 A TW109139793 A TW 109139793A TW 109139793 A TW109139793 A TW 109139793A TW 202132269 A TW202132269 A TW 202132269A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- log
- copies
- series
- dengue
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19209593.3 | 2019-11-15 | ||
| EP19209593 | 2019-11-15 | ||
| EP19213851.9 | 2019-12-05 | ||
| EP19213851 | 2019-12-05 | ||
| EP20171172 | 2020-04-23 | ||
| EP20171172.8 | 2020-04-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202132269A true TW202132269A (zh) | 2021-09-01 |
Family
ID=73288639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109139793A TW202132269A (zh) | 2019-11-15 | 2020-11-13 | 登革熱疾病及治療和預防 |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119173261A (zh) * | 2022-05-12 | 2024-12-20 | 杨森制药公司 | 登革热病毒感染的治疗和/或预防 |
| WO2025248536A1 (en) * | 2024-05-29 | 2025-12-04 | Zydus Lifesciences Limited | Novel oxime derivatives to treat viral infections |
| WO2025253267A1 (en) | 2024-06-06 | 2025-12-11 | Janssen Pharmaceuticals, Inc. | Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1200899A (en) | 1997-10-27 | 1999-05-17 | Eli Lilly And Company | Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors |
| EP1261610A2 (en) | 2000-02-17 | 2002-12-04 | Bristol-Myers Squibb Pharma Company | Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production |
| GB0110832D0 (en) | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
| EP1519735A4 (en) | 2001-12-12 | 2006-01-11 | Conforma Therapeutic Corp | ASSAYS AND DEVICES FOR DETERMINING AND MODULATING HSP90 BINDING ACTIVITY |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| EP1749007A2 (en) | 2004-03-30 | 2007-02-07 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
| NZ555142A (en) | 2004-12-23 | 2010-03-26 | Novartis Ag | Compounds for flaviviridae treatment |
| CN101103026A (zh) | 2005-01-14 | 2008-01-09 | 健亚生物科技公司 | 用于治疗病毒感染的吲哚衍生物 |
| AU2006221080A1 (en) | 2005-02-09 | 2006-09-14 | Migenix Inc. | Compositions and methods for treating or preventing flaviviridae infections |
| DE102005028845A1 (de) | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| WO2007017093A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted 2-benzyloxy-benzoic acid amide derivatives |
| CN101253152A (zh) | 2005-09-02 | 2008-08-27 | 安斯泰来制药株式会社 | 作为rock抑制剂的酰胺衍生物 |
| FR2928645A1 (fr) | 2008-03-14 | 2009-09-18 | Sanofi Aventis Sa | Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
| CN102056483A (zh) | 2008-06-03 | 2011-05-11 | 西佳技术公司 | 用于治疗或预防登革病毒感染的小分子抑制剂 |
| MX2011001872A (es) | 2008-08-18 | 2011-05-23 | Univ Yale | Moduladores de mif. |
| EP2331499B1 (en) | 2008-08-19 | 2016-09-21 | Janssen Pharmaceutica NV | Cold menthol receptor antagonists |
| TWI453207B (zh) | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶,其組合物及使用其之治療方法 |
| WO2010091413A1 (en) | 2009-02-09 | 2010-08-12 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| US8993604B2 (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections |
| CA2771124C (en) | 2009-09-09 | 2019-01-15 | Gilead Sciences, Inc. | Inhibitors of flaviviridae viruses |
| EA201290575A1 (ru) | 2010-01-15 | 2013-01-30 | Джилид Сайэнс, Инк. | Ингибиторы вирусов flaviviridae |
| WO2011120025A1 (en) | 2010-03-26 | 2011-09-29 | Glaxo Group Limited | Indazolyl-pyrimidines as kinase inhibitors |
| JP5716205B2 (ja) | 2011-03-29 | 2015-05-13 | 学校法人日本大学 | グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法 |
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| MX368158B (es) | 2013-10-23 | 2019-09-20 | Janssen Sciences Ireland Uc | Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b. |
| JP6505727B2 (ja) | 2014-01-31 | 2019-04-24 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | ヘテロ環式p2’基を有する第xia因子阻害剤としてのマクロ環 |
| KR102382905B1 (ko) | 2014-06-04 | 2022-04-04 | 프레드 헛친슨 켄서 리서치 센터 | 노치 1 및/또는 노치 2 작용제를 사용한 줄기 세포의 확장 및 생착 |
| KR102391259B1 (ko) | 2014-06-04 | 2022-04-26 | 암젠 인크 | 포유류 세포 배양물을 회수하는 방법 |
| BR112017006708A2 (pt) | 2014-10-01 | 2017-12-26 | Janssen Pharmaceuticals Inc | indóis mono- ou dissubstituídos como inibidores da replicação viral de dengue |
| US9944598B2 (en) | 2014-10-01 | 2018-04-17 | Janssen Pharmaceuticals, Inc. | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors |
| NO2721243T3 (cg-RX-API-DMAC7.html) | 2014-10-01 | 2018-10-20 | ||
| ES2896198T3 (es) | 2014-10-10 | 2022-02-24 | Univ Rutgers | Cebadores y sondas de reacción en cadena de polimerasa para Mycobacterium tuberculosis |
| PH12017501272B1 (en) | 2015-01-16 | 2023-01-11 | Janssen Pharmaceuticals Inc | Indole derivatives as dengue viral replication inhibitors |
| AR103680A1 (es) | 2015-02-23 | 2017-05-24 | Lilly Co Eli | Inhibidores selectivos de bace1 |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JP6636133B2 (ja) | 2015-07-22 | 2020-01-29 | オメイコス セラピューティクス ゲーエムベーハー | 心疾患の治療に対するcyp−エイコサノイドの代謝的にロバストな類縁体 |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CA3002214C (en) | 2015-11-03 | 2022-01-04 | Zoetis Services Llc | Sol-gel polymer composites and uses thereof |
| EP3433274A1 (en) | 2016-03-25 | 2019-01-30 | Visterra, Inc. | Formulation of antibody molecules to dengue virus |
| WO2017167953A1 (en) | 2016-03-31 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
| HRP20210847T1 (hr) | 2016-03-31 | 2021-07-23 | Janssen Pharmaceuticals, Inc. | Supstituirani derivati indola kao inhibitori replikacije denga virusa |
| UY37174A (es) | 2016-03-31 | 2017-10-31 | Takeda Pharmaceuticals Co | Un compuesto heterocíclico que tiene una acción inhibidora de monoacilglicerol lipasa |
| AU2017240801A1 (en) | 2016-04-01 | 2018-10-25 | Amgen Inc. | Chimeric receptors to FLT3 and methods of use thereof |
| KR102427334B1 (ko) | 2016-04-01 | 2022-08-03 | 카이트 파마 인코포레이티드 | 키메라 항원 및 t 세포 수용체 및 사용 방법 |
| US10576085B2 (en) | 2016-04-01 | 2020-03-03 | Signal Pharmaceuticals, Llc | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith |
| EA201892200A1 (ru) | 2016-04-01 | 2019-03-29 | Янссен Фармасьютикалз, Инк. | Замещенные производные соединений индола в качестве ингибиторов репликации вирусов денге |
| SG10201912519VA (en) | 2016-04-01 | 2020-02-27 | Kite Pharma Inc | Chimeric receptors and methods of use thereof |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| MX2018012016A (es) | 2016-04-01 | 2019-01-24 | Basf Se | Compuestos biciclicos. |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CR20190531A (es) | 2017-05-22 | 2020-03-05 | Janssen Pharmaceuticals Inc | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue |
| CA3060583C (en) | 2017-05-22 | 2024-06-04 | Janssen Pharmaceuticals, Inc. | Substituted indoline derivatives as dengue viral replication inhibitors |
-
2020
- 2020-11-13 PH PH1/2022/551160A patent/PH12022551160A1/en unknown
- 2020-11-13 CN CN202080093897.0A patent/CN114980884A/zh active Pending
- 2020-11-13 BR BR112022009199A patent/BR112022009199A2/pt unknown
- 2020-11-13 JP JP2022528008A patent/JP2023502053A/ja active Pending
- 2020-11-13 TW TW109139793A patent/TW202132269A/zh unknown
- 2020-11-13 UA UAA202202003A patent/UA129409C2/uk unknown
- 2020-11-13 EP EP20803432.2A patent/EP4058019A1/en not_active Withdrawn
- 2020-11-13 WO PCT/EP2020/082102 patent/WO2021094563A1/en not_active Ceased
- 2020-11-13 KR KR1020227020173A patent/KR20220101679A/ko not_active Ceased
- 2020-11-13 IL IL292970A patent/IL292970A/en unknown
- 2020-11-13 AU AU2020382911A patent/AU2020382911A1/en not_active Abandoned
- 2020-11-13 US US17/777,019 patent/US12702657B2/en active Active
- 2020-11-13 CA CA3161338A patent/CA3161338A1/en active Pending
- 2020-11-13 MX MX2022005879A patent/MX2022005879A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4058019A1 (en) | 2022-09-21 |
| UA129409C2 (uk) | 2025-04-16 |
| US12702657B2 (en) | 2026-08-11 |
| MX2022005879A (es) | 2022-06-14 |
| KR20220101679A (ko) | 2022-07-19 |
| IL292970A (en) | 2022-07-01 |
| AU2020382911A1 (en) | 2022-06-30 |
| CN114980884A (zh) | 2022-08-30 |
| JP2023502053A (ja) | 2023-01-20 |
| CA3161338A1 (en) | 2021-05-20 |
| WO2021094563A1 (en) | 2021-05-20 |
| PH12022551160A1 (en) | 2023-09-25 |
| BR112022009199A2 (pt) | 2022-07-26 |
| US20220409583A1 (en) | 2022-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240269125A1 (en) | Methods of treating coronavirus infections by co-administering an fkbp ligand and an antiviral agent | |
| CN105636589B (zh) | 脱氧野尻霉素衍生物及其使用方法 | |
| KR20220101679A (ko) | 뎅기열 질환의 치료 및 예방 | |
| CN109789147B (zh) | 用于治疗非酒精性脂肪性肝病的药物组合物及方法 | |
| EP4129290B1 (en) | Pharmaceutical composition comprising pyronaridine or a salt thereof, artemisinin or a derivative thereof or a combination of both for preventing or treating a respiratory disease caused by a coronavirus | |
| RU2518314C2 (ru) | Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами | |
| JP2001072585A (ja) | ウイルス性心筋炎の予防または治療薬剤 | |
| CN116940360B (zh) | 5-硝基-8-羟基喹啉的应用 | |
| WO2014169355A1 (en) | Method of viral inhibition | |
| EA049504B1 (ru) | Лечение и профилактика лихорадки денге | |
| HK40074715A (en) | Treatment and prevention of dengue disease | |
| WO2023070058A1 (en) | Treatment of viruses with antiviral nucleosides | |
| CN113440527B (zh) | 萘酚喹或含萘酚喹的组合制剂在抗冠状病毒中的应用 | |
| US20210186976A1 (en) | Methods and compositions for treatment of zika virus infection | |
| CN102335171A (zh) | 一类n-(2-噻唑)苯甲酰胺衍生物的应用 | |
| RU2843665C1 (ru) | Фармацевтическая композиция для профилактики или лечения эпидемического рнк-вирусного инфекционного заболевания | |
| EP4403177A1 (en) | New combination drug for treating coronavirus infections, pharmaceutical composition and use thereof | |
| EP3960173B1 (en) | Enterovirus inhibitor | |
| CN106727574A (zh) | 马尼地平在制备治疗黄病毒科病毒感染药物中的应用 | |
| WO2017202789A1 (en) | Methods and pharmaceutical compositions for the treatment of filovirus infections | |
| Yang et al. | Norovirus: Clinical Findings and Pharmaceutical Developments | |
| WO2025133697A2 (en) | Combination therapy for inhibition of ebolavirus | |
| CN121466087A (zh) | Pha-767491在制备防治h1n1亚型猪流感药物中的应用 | |
| EA025610B1 (ru) | Антивирусная композиция и ее применение | |
| KR20250002212A (ko) | 인플루엔자 및 폭스바이러스 바이러스 감염을 치료하는 방법 |